Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Jury finds Lallemand Did Not Willfully Infringe DSM's Patent

Lallemand Inc.
Posted on: 18 May 18
Jury finds Lallemand Did Not Willfully Infringe DSM's Patent

PR Newswire

MONTREAL, May 17, 2018

MONTREAL, May 17, 2018 /PRNewswire/ -- As part of an ongoing intellectual property dispute between DSM and Lallemand, a jury in Madison, Wisconsin this week delivered a verdict finding that certain Lallemand TransFerm® products infringe United States Patent No. 8,795,998. While Lallemand very much respects the legal process, we were surprised by this outcome and will vigorously contest it in further court proceedings.

Lallemand champions innovation and fair competition, and respects valid intellectual property rights. The jury in Wisconsin heard evidence of Lallemand's position that it is practicing its own patented technology. As a result, the jury returned a verdict that Lallemand did not willfully infringe on the DSM patent, concluding that Lallemand reasonably believed that it used its own intellectual property.

Lallemand, through its Lallemand Biofuels & Distilled Spirits (LBDS) business unit, is a leading supplier of fermentation ingredients (yeast, yeast nutrients and antimicrobials) and value-creating services to biofuel producers. Through ongoing innovation and continuous learning about the value-drivers for our customers, Lallemand will continue to deliver products and services to the biofuels industry that drive results. The ongoing legal process cannot stop this continuing commitment to our customers.

About Lallemand

Lallemand Inc. is a privately-held Canadian company, and is a leading developer, producer and marketer of yeasts, bacteria and other microorganisms serving the baking, winemaking, distilling, ethanol, brewing, animal nutrition, dietary supplements, food, fermentation, pharmaceutical and plant care industries. Lallemand has more than 3,700 employees located in over 40 countries, and is active on all five continents. For more information visit www.lallemand.com.

About Lallemand Biofuels & Distilled Spirits

Lallemand Biofuels & Distilled Spirits (LBDS) is a business unit of Lallemand, Inc. Based in Duluth, GA, Lallemand Biofuels & Distilled Spirits is the leading supplier of fermentation ingredients and value creating services to the global fuel ethanol and distilled beverage industries. For more information on LBDS, please visit www.lbds.com.

Contact: 

Lallemand Inc.
Roberto Blanc, Marketing and Communications Director
Tel.: +1 (514) 906-9902
E-Mail: Marketing.Global@lallemand.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/jury-finds-lallemand-did-not-willfully-infringe-dsms-patent-300650824.html

SOURCE Lallemand Inc.

PR Newswire
www.prnewswire.com

Last updated on: 18/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.